Dhanunjaya Lakkireddy, MD, FACC
11
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
36.4%
4 terminated/withdrawn out of 11 trials
63.6%
-22.9% vs industry average
18%
2 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes
Role: lead
Brain Perfusion and Hemodynamic Stability in Patients Undergoing Radiofrequency Ablation of Ventricular Tachycardia
Role: lead
Use of a Novel Contact Force Sensing Catheter for AF Ablation - Impact of TactiCath on Dormant Conduction Across the Pulmonary Veins
Role: lead
Yoga and Rate and Duration of Inappropriate Sinus Tachycardia (IST) Episodes
Role: lead
Influence of Yoga in Patients With Neurocardiogenic Syncope
Role: lead
Hybrid AF -- A Prospective Registry
Role: lead
Incidence & Predictors of Mechanical Abnormalities of QuickSite® and QuickFlex® Left Ventricular Pacing Leads
Role: lead
MAKE IT CLEAN, Impact of Pocket Revision on the Rate of Infection and Other Complications in Patients Requiring Pocket Manipulation for Generator Replacement and/or Lead Replacement or Revision: A Prospective Randomized Study
Role: lead
Atrial Fibrillation Ablation on Gastric Motility "The AF Gut Study"
Role: lead
Yoga on Arrhythmia Burden and Quality of Life in Paroxysmal Atrial Fibrillation
Role: lead
Comparison of External Event Recorders for Atrial Fibrillation Monitoring
Role: lead
All 11 trials loaded